UK drugmaker in China bribery probe

GlaxoSmithKline's British and Chinese executives accused of paying off health institutions to use their pricey products.

    Police in China have completed an investigation into a suspected bribery case involving the multinational pharmaceutical company GlaxoSmithKline (GSK) and handed it over to prosecutors on Wednesday.

    After an almost year-long investigation, police alleged that William Mark Reilly, a British national and executive of GSK China, and two Chinese executives, Zhang Guowei and Zhao Hongyan, bribed Chinese hospitals, doctors and health institutions, to use their products.

    The drugmaker GSK China used illegal means to maximise profit, its former employees alleged.

    Al Jazeera's Tim Friend reports from London.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    Meet the deported nurse aiding asylum seekers at US-Mexico border

    Meet the deported nurse helping refugees at the border

    Francisco 'Panchito' Olachea drives a beat-up ambulance around Nogales, taking care of those trying to get to the US.

    The rise of Pakistan's 'burger' generation

    The rise of Pakistan's 'burger' generation

    How a homegrown burger joint pioneered a food revolution and decades later gave a young, politicised class its identity.

    'We will cut your throats': The anatomy of Greece's lynch mobs

    The brutality of Greece's racist lynch mobs

    With anti-migrant violence hitting a fever pitch, victims ask why Greek authorities have carried out so few arrests.